Baillie Gifford & Co
CELG

Baillie Gifford & Co’s Celgene Corp CELG Stock Holding History

Baillie Gifford & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-78,398
Closed -$7.4M – 233
2019
Q1 		$7.4M Sell
78,398
-980,113
-93% -$85.7M 0.01% 193
2018
Q4 		$67.8M Buy
1,058,511
+148,142
+16% +$10.9M 0.09% 103
2018
Q3 		$81.5M Buy
910,369
+50,483
+6% +$4.46M 0.09% 101
2018
Q2 		$68.3M Buy
859,886
+37,770
+5% +$3.14M 0.07% 104
2018
Q1 		$73.3M Buy
822,116
+104,622
+15% +$10M 0.09% 95
2017
Q4 		$74.9M Buy
717,494
+44,198
+7% +$4.99M 0.09% 94
2017
Q3 		$98.2M Buy
673,296
+8,329
+1% +$1.13M 0.12% 88
2017
Q2 		$86.4M Sell
664,967
-2,418
-0.4% -$296K 0.12% 86
2017
Q1 		$83M Sell
667,385
-3,703
-0.6% -$443K 0.12% 85
2016
Q4 		$77.7M Buy
671,088
+12,144
+2% +$1.35M 0.13% 84
2016
Q3 		$68.9M Buy
+658,944
New +$71.3M 0.11% 86
2013
Q4 		– Sell
-6,966
Closed -$536K – 227
2013
Q3 		$536K Hold
6,966
– – ﹤0.01% 177
2013
Q2 		$407K Buy
+6,966
New +$419K ﹤0.01% 149

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Baillie Gifford & Co's CELG Position: Q2 2019 in Review

Baillie Gifford & Co sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 78,398 shares — an estimated $7.4M sold.

Baillie Gifford & Co first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $98.2M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Baillie Gifford & Co reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Baillie Gifford & Co sold 78,398 Celgene Corp shares in Q2 2019, an estimated $7.4M.
  • Baillie Gifford & Co first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
  • Baillie Gifford & Co's Celgene Corp position peaked at $98.2M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Baillie Gifford & Co's 13F filing for Q2 2019, filed 8 Aug 2019.